|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 6 of 15 found articles
| Title: |
First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆ |
| Author: |
Niu, J. Maurice-Dror, C. Lee, D.H. Kim, D.-W. Nagrial, A. Voskoboynik, M. Chung, H.C. Mileham, K. Vaishampayan, U. Rasco, D. Golan, T. Bauer, T.M. Jimeno, A. Chung, V. Chartash, E. Lala, M. Chen, Q. Healy, J.A. Ahn, M.-J. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 33 () nr. 2 pages 169-180 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, The Author(s) |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 6 of 15 found articles
| << previous | next >> |